MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1080/13506129.2026.2640984

Медицинская библиотека · Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis · 2026

Serum peripherin as a disease biomarker in hereditary transthyretin amyloidosis: a multicenter cohort study.

Plantone Domenico, Righi Delia, Romano Angela, Leonardi Luca, Guglielmino Valeria, Forcina Francesca, Ceccanti Marco, Inghilleri Maurizio, Manganelli Fiore, Tozza Stefano, Sciarrone Maria Ausilia, Vitali Francesca, Sabino Andrea, Manco Carlo, Stufano Angela, Stromillo Maria Laura, De Stefano Nicola, Calabresi Paolo, Primiano Guido, Luigetti Marco

СтатьяМногоцентровое исследованиеНаблюдательное исследованиеПеревод пока не подготовлен

Аннотация

BACKGROUND

Hereditary transthyretin amyloidosis (ATTRv, v for variant) is a rare, progressive, and fatal multisystemic disease. Peripherin represents a promising biomarker for axonal damage in the peripheral nervous system (PNS). This study aims to investigate serum peripherin levels in symptomatic and presymptomatic ATTRv subjects, alongside serum neurofilament light chain (sNfL) levels, and their correlations with disease progression and severity.

METHODS

This multicenter, cross-sectional cohort study included 96 individuals with TTR gene variants (49 presymptomatic and 47 symptomatic ATTRv subjects) and 42 healthy controls (HCs). Serum peripherin levels were measured using a highly sensitive homebrew immunoassay, whereas sNfL levels were determined using a commercially available Simoa Neurology 2-Plex B assay. Statistical analyses included non-parametric Spearman correlations, Kruskal-Wallis ANOVA, ANCOVA, and binomial logistic regression.

RESULTS

Serum peripherin levels were elevated in both presymptomatic (p < 0.001) and symptomatic ATTRv groups (p < 0.001) compared to HCs. Peripherin levels did not correlate with age, sNfL levels, or clinical severity, but showed a strong discriminative ability between ATTRv and HCs (AUC = 0.83, sensitivity = 76%, specificity = 76%, p < 0.001).

CONCLUSIONS

This study demonstrates that serum peripherin represents a promising biomarker for early detection of PNS damage in ATTRv, with elevated levels detectable even in presymptomatic stages.

Для цитирования: Plantone Domenico, Righi Delia, Romano Angela, Leonardi Luca, Guglielmino Valeria, Forcina Francesca, Ceccanti Marco, Inghilleri Maurizio, Manganelli Fiore, Tozza Stefano, Sciarrone Maria Ausilia, Vitali Francesca, Sabino Andrea, Manco Carlo, Stufano Angela, Stromillo Maria Laura, De Stefano Nicola, Calabresi Paolo, Primiano Guido, Luigetti Marco. Serum peripherin as a disease biomarker in hereditary transthyretin amyloidosis: a multicenter cohort study.. Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis. 2026. DOI: 10.1080/13506129.2026.2640984.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.